| D-0384-2026 | Class II | Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: | March 3, 2026 |
| D-0029-2026 | Class II | Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufacture | October 7, 2025 |
| D-0277-2025 | Class II | Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising | March 5, 2025 |
| D-0190-2025 | Class II | Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-9 | December 30, 2024 |
| D-0188-2025 | Class II | Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC | December 30, 2024 |
| D-0189-2025 | Class II | Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pha | December 30, 2024 |
| D-0105-2025 | Class II | Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed by: Rising Ph | November 19, 2024 |
| D-0107-2025 | Class II | Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c | November 19, 2024 |
| D-0106-2025 | Class II | Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC 572 | November 19, 2024 |
| D-0599-2024 | Class III | Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Bro | June 24, 2024 |
| D-0541-2024 | Class III | Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. | May 16, 2024 |
| D-0222-2024 | Class II | buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufac | December 29, 2023 |